Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?

Glutsch, V

Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma? [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology 10 2019 - 1667-1668 p. digital

Publication Type: Case Reports; Journal Article

1569-8041

10.1093/annonc/mdz230 doi


Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Merkel Cell--drug therapy
Drug Resistance, Neoplasm--drug effects
Humans
Ipilimumab--administration & dosage
Male
Middle Aged
Nivolumab--administration & dosage
Prognosis
Skin Neoplasms--drug therapy